FDA recall D-0418-2026

Amerisource Health Services LLC · Class II · drug

Product

Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217.

Reason for recall

Failed tablet specifications.

Distribution

U.S. Nationwide

Key facts

Status: Ongoing
Initiation date: 2026-03-16
Report date: 2026-04-01
Voluntary/Mandated: Voluntary: Firm initiated
Location: Columbus, OH, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0418-2026